key: cord-0908945-l5v4e20a
authors: van der Velden, P. G.; Marchand, M.; Das, M.; Muffels, R.; Bosmans, M.
title: The prevalence, incidence and risk factors of mental health problems and mental health services use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study.
date: 2021-03-02
journal: nan
DOI: 10.1101/2021.02.27.21251952
sha: ba40eeb0835f0aaf2e723a350d461d25c14c9282
doc_id: 908945
cord_uid: l5v4e20a

Objectives. Gain insight in the effects of the COVID-19 pandemic on the prevalence, the incidence and risk factors of mental health problems among the Dutch general population and different age groups in November-December 2020, compared to the prevalence, incidence, and risk factors in the same period in 2018 and 2019. More specifically, the prevalence, incidence and risk factors of anxiety and depression symptoms, sleep problems, fatigue, disabilities due to health problems, use of medicines for sleep problems, medicines for anxiety and depression, and mental health services use. Methods. We extracted data from the LISS (Longitudinal Internet studies for the Social Sciences) panel that is based a probability sample of the Dutch population of 16 years and older by Statistics Netherlands. We used three waves of the longitudinal Health module held in November-December 2018 (T1), November-December 2019 (T2) and November-December 2020 (T3), and selected respondents who were 18 years and older at T1. Data were weighted using 16 demographics profiles of the Dutch adult population (Nstudy sample=4,064). The course of mental health problems was examined with repeated measures multivariate logistic regression analyses, and the differences in incidence with multivariate logistic regression analyses. In both types of analyses, we controlled for sex, age, marital status, employment status, education level and physical disease. Results. The repeated measures multivariate logistic regression analyses among the total study sample did not reveal a significant increase in the prevalence of anxiety and depression symptoms, sleep problems, fatigue, disabilities due to health problems, use of medicines for sleep problems, medicines for anxiety and depression, and mental health services use in November-December 2020, compared to November-December 2018 and 2019 (that is, T3 did not differ from T1 and T2). Among the four different age categories (18-34, 35-49, 50-64, and 65 years old and older respondents), 50-64 years respondents had a significantly lower prevalence of anxiety and depression symptoms at T3 than at T1 and T2, while T1 and T2 did not differ. A similar pattern among 65+ respondents was found for mental health services use. We found no indications that the incidence of examined health problems at T2 (no problem at T1, problem at T2) and T3 (no problem at T2, problem at T3) differed. Risk factors for mental health problems at T2 were mostly similar to risk factors at T3; sex and age were less associated with sleep problems at T3, compared to T2. Conclusions. The prevalence, incidence and risk factors of examined mental health problems examined nine months after the COVID-19 outbreak appear to be very stable across the end of 2018, 2019 and 2020 among the Dutch adult population and different age categories, suggesting that the Dutch adult population (20 years and older) in general is rather resilient given all disruptions due to this pandemic.

7 were asked about symptoms in the last seven days. McGinty et al. [14] also compared the mental health of adults before and after the outbreak of two different samples, e.g., respondents in the NHIS in 2018 and the Johns Hopkins COVID- 19 Civic Life and Public Health Survey in April 2020. According to the Kessler's K6 Scale, in the first sample (2018) serious psychological distress was significantly lower (3.9%) than in the second sample (13.6%, April 2020). In April 2020, symptoms of psychological distress were highest among young adults aged 18 to 29 years who suffered from an increase of problems (20.8% and 14.4% respectively) was higher than among those of 60 years and older. Ettman et al. [17] compared the prevalence of depression symptoms (mild, moderate, moderately severe, severe) according to the PHQ-9 among . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.27.21251952 doi: medRxiv preprint respondents of the COVID- 19 Life Stressors Impact on Mental Health and Well-being study conducted in the period March 31, 2020-April 13, 2020 and, like Daly et al. [15] , the NHNE Survey conducted in 2017-2018. Results showed that the depression symptom prevalence was higher in every category during COVID-19 than before (mild: 24.6% vs 16.2%, moderate:

14.8% vs 5.7%, moderately severe: 7.9% vs 2.1%, severe: 5.1% vs 0.7%). In addition, in contrast to pre-COVID-19, during COVID-19 moderate to severe depression symptom levels differed between age categories with higher prevalence among younger adults (18-39 years old: 38 .8%, 40-59 years old: 26.8%, and ≥ 60 years old: 14.9%). Van der Velden [20] with data up to June 2020, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) [16, 18, 19] .

In sum, prospective studies in the UK all showed an increase in mental health problems among especially 18-35 years old respondents during the first months after the COVID-19 outbreak compared to previous years. With respect to the US, findings are mixed to some extent. In the prospective study of Breslau et al. [16] among respondents who participated in both waves no differences in mental health problems were found. The other prospective studies [13] [14] [15] [16] [17] , that extracted data on mental health from different pre-and post-COVID-outbreak samples in the US, showed an increase in the prevalence of mental health problems. Studies using the Dutch population-based LISS panel found no evidence that mental health problems among the Dutch general population increased, although 35-49 years old respondents were more and 65+ respondents were less at risk of mental health problems than 18-34 years old respondents in

To what extent the ongoing COVID-19 pandemic and individual and societal consequences affect the mental health of the general population on the longer term (later than June 2020) is unknown. In addition, current prospective studies mainly focused on psychological . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 2, 2021. Statistics Netherlands (CBS) reported that about 169,000 had died in the Netherlands in 2020, 10% more than expected compared to previous years [26] . This increase is very likely due to COVID-19.

For the present study, data on mental health were extracted from the Longitudinal Internet studies https://www.dataarchive.lissdata.nl; in English). As described above, this panel was also used in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

We used the following six measures administered in each survey to obtain insight in the mental health problems and mental health services use of respondents in November-December 2018, 2019 and 2020. At each survey respondents' sex, age, marital status and employed status was assessed. For the present study, marital status and employed status were recoded in married (1= yes, 2= no) and employed (1=no, 2= yes).

Anxiety and depression symptoms. Anxiety and depression symptoms were examined using the Mental Health Index or Inventory (5-item sub scale of the MOS 36-item short-form health survey [28, 29] . Respondents were asked to rate their mental health during the past month on 6-point Likert scales (5=never to 0=continuously). After recoding the positive formulated third and fifth item, the total scores were computed and multiplied by four (all Cronbach's α > 0.85; range 0 to 100). Lower scores reflect higher symptom levels. A cut-off of ≤ 59 was used to identify respondents with moderate to severe symptom levels and a cut-off of ≤ 44 to identify respondents with severe symptom levels [30] .

Fatigue and sleep problems. Respondents were furthermore administered a list of 10 (physical) problems people may suffer from, varying from heart complaints to sleeping problems.

For the present study we focused on the items 'Do you regularly suffer from fatigue' and 'Do you regularly suffer from sleep problems' (1=no, 2=yes).

independently associated with increased disability [31] . Health-related disabilities were assessed . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; [32] , and had 5-point Likert scale (1=not at all to 5=very much). For the present study scores were recoded into low (1=1,2,3) and high (2=4,5).

Use of medicines were assessed for various conditions varying from medicines for blood pressure to sleep problems ( 'Are you currently taking medicine at least once a week for .. '). For the present study we focused on current use of medicines for anxiety and depression symptoms and sleep problems (0=no, 1=yes).

Mental health services use. The use of mental health services (MHS) was assessed by one question 'How often did you use the following health services over the past 12 months?', with answer categories varying from psychiatrist/ psychologist/ psychotherapist to dentist. For the present study, we focused on the use of a psychiatrist, psychologist, or psychotherapist and recoded 'use' into 'no' (0=no use) and 'yes' (1=once or more) in the past 12 months.

Physical disease. Respondents were administered a list of 19 physical diseases/ problems and asked if they had one of more of these diseases/problems according to a physician ('Has a physician told you this last year that you suffer from one of the following diseases/ problems?')

varying from cancer to a chronic lung disease. For the represent study we recoded the answers into 'no disease' (1=none of the diseases/problems included in 'diseases') and 'disease'

(including: (2= angina, pain in the chest a heart attack including infarction or coronary thrombosis or another heart problem including heart failure; a stroke or brain infarction or a disease affecting the blood vessels in the brain diabetes or a too high blood sugar level; chronic lung disease such as chronic bronchitis or emphysema; asthma; arthritis, including osteoarthritis, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; 1 5 or rheumatism, bone decalcification or osteoporosis; cancer or malignant tumor, including leukemia or lymphoma; and/or benign tumor (skin tumor, polyps, angioma)).

To examine the extent to which the prevalence of the seven assessed mental health problems after the For the incidence at T3 (prevalence of new cases), the prevalence of mental health problems and use at T3 was assessed among those without these problems and or use at T2.

Likewise, for the incidence at T2, problems and use at T2 were assessed among those without these problems and use at T1 (the incidence at T1 could not be computed among the current study sample). To assess the extent to which the incidence of mental health problems and use in November-December 2020 (T3) changed compared to the incidence in November-December 2019 (T2), multivariate logistic regression were conducted as follows. The incidence at T2 and T3 cannot directly be compared because those with problems and use at T2 and T3 without problems and use at the previous survey partly overlap. To enable a comparison of the incidence at T2 and T3, we therefore first randomly split the total study sample into two almost equal independent subgroups of respondents (A: n=2,025; and B: n=2,019; because of the weighting the numbers of both groups slightly differs). Of both subgroups the incidence at T2 (A1, B1) and

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; 1 6 T3 (A2, B2) were computed. We finally compared the incidence of A1 with B2 and compared the incidence of B1 with A2 using multivariate logistic regression with the same control variables as in the RMMLR analyses (on T1 for analyses incidence at T2, on T2 for analyses incidence at T3).

Prospective risk factors of mental health problems and services use were examined using multivariate logistic regression analyses with problems and services use at T2 and T3 as dependent variables. The variables sex, age, education level, marital status, employment status and physical disease at T1 and T2 respectively were simultaneously entered as predictors (for instance, variables at T2 were entered as predictors for problems at T3). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ;

1 7

The characteristic of the study sample are presented in Table 1 . It shows, among others, that in absolute numbers as time passes by more respondents are married, become older, have a higher education level, as well as more often have a physical disease. At T3 the youngest respondents were 20 years old.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

The prevalence of the assessed mental health problems and services use among the total study sample at T1, T2 and T3 are presented in Table 2 . According to the repeated measures multivariate logistic regression analyses, the prevalence of mental health problems and services use at T3 did not significantly differ from T1 and T2 except for disabilities due to health problems. The prevalence of disabilities due to health problems was significantly lower at T3

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; 1 9 (8.5%) than at T1 (9.9%), but not significantly different from the prevalence at T2 (8.5%).

Analyses for anxiety and depression scores using the cut-off score of ≤ 44 of the MHI-5 showed similar outcomes: the prevalence of severe symptom levels at T1 (6.6%), T2 (6.5%) and T3 (6.3%) did not differ significantly.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) For fatigue, no significant changes in the prevalence were found between T1, T2 and T3 across the four age categories. Only among respondents 50-64 years old the prevalence of disabilities due to health problems differed significantly to some extent: the prevalence was lower at T3 (10.6%) compared to T1 (12.2; aOR=0.78, 95% CI= 0.62-0.99, p=0.039, but not compared to T2 (10.0%).

The use of medicine for anxiety and depression among respondents 18-34 years old was significant more prevalent at T3 (3.4%) than at T2 (2.9%; aOR=1.21, 95% CI=1.01-1.46, p=0.040) but not at T1. Concerning the use of medicines for sleep problems, no significant changes in the prevalence were found between T1, T2 and T3 across the four age categories.

Finally, the use of mental health professionals among respondents of 65 years old and older decreased significantly in the 12 months before T3 (2.2%) compared to T1 (3.5%; aOR=0.60, 95% CI=0.41-0.87, p=0.006) and T2 (3.1%; aOR=0.69, 95% CI=0.49-0.97, p=0.031).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.27.21251952 doi: medRxiv preprint No significant differences were found between T1 and T2 (for details, see S1 Appendix Age categories). Table 3 shows the incidence of mental health problems and services use at T2 and T3 among the total study sample and the results of crosswise multivariate logistic regression analyses, showing that the incidence of the mental health problems and services use at T2 and T3 did not differ significantly. Similar analyses using the cut-off ≤ 44 of the MHI-5 showed that the incidence of severe anxiety and depression symptom levels at T2 (3.7%) and T3 (3.3%) did not significantly differ (results not shown in table).

Due to the cell counts of the incidence of mental health problems and services use at T2 and T3 (see Table 3 ) we limited the (cross-wise) analyses multivariate logistic regression analyses among the four age categories to the incidence of anxiety and depression symptoms. The eventsper-variable (EPV) ratio for the other dependent variables, with seven predictors including control variables, became lower than 10. The results of these analyses showed no significant differences in incidence between T2 and T3 among 18-34 years old respondents (T2 incidence =12.4%, T3 incidence =13.1%), 35-49 years old respondents (T2 incidence =9.9%, T3 incidence =9.7%), 50-64 years old respondents (T2 incidence =6.2%, T3 incidence =5.0%), and 65 years and older respondents (T2 incidence =6.1%, T3 incidence =4.8%). Using the cut-off ≤ 44 of the MHI-5 also did not reveal significant differences between the T2 and T3 incidence (results not shown in table).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. 1 Prevalence mental health problems among those without problems /use on previous survey. 2 According to cut-off score of ≤ 59 on MHI-5. 3 Psychiatrist/psychologist/psychotherapist in past 12 months. n.a.=not available because 2017 survey was outside aim of this study. aOR=Odds ratio of logistic regression analyses, adjusted for sex, age, marital status, employment status, education level and disease at T1 and T2, and T2 and T3. 95% CI= 95% confidence interval for aOR. A1=incidence T2 of subgroup A. B1=incidence T2 of subgroup B. A2=incidence T3 of subgroup A. B2=incidence T3 of subgroup B. All results are based on the weighted sample. Due to weighting numbers may slightly differ between tables.

.

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint 

In Table 4 , the results of the multivariate logistic regression analyses are presented (for 95% confidence intervals of the adjusted OR's, see S2 Appendix Risk factors). Table 4 shows that existing mental health problems and services use (e.g., assessed one year earlier) were by far the strongest predictors for problems and use before and after the COVID-19 outbreak. For example, about 90% of the respondents with existing sleep problems and fatigue T1 and T2, had sleep problems and fatigue at T2 and T3, respectively. With respect to anxiety and depression symptoms at T2 and T3, almost the same predictors were significant for these symptoms at T2 and T3: only those with a medium education level were no longer less at risk of symptoms than those with a relatively low education level. An almost similar pattern can be observed for sleep problems: only males and females did no longer differ in sleep problems after the outbreak (T3).

However, 35-49 years old respondents were more at risk of sleep problems after the outbreak (at T3), but not before (at T2), relative to 65+ respondents. The patterns of risk factors of fatigue at T2 and T3 are identical. For disabilities due to health problems, e.g. that physical health or emotional problems hinder respondents work over the past month, for instance in their job, housekeeping, or in school, results show that significant differences between subgroups disappeared after the outbreak: those with a medium and high education level compared to those with a relative low level, males compared to females, and youngest adult group (18-34 years) compared to 65+ respondents no longer differed in disabilities due to health problems. Finally, for mental health services use those employed before the outbreak (T2) used services significantly less often services after the outbreak (T3) than unemployed, in contrast to the period before the outbreak (T1-T2). Because of the relative low prevalence of medicines for . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; 2 5 anxiety/depression and medicines for sleep problems, we have omitted these dependent variables from the analyses.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint The main conclusion that can be drawn from the present study is that the prevalence, the incidence as well as risk factors of the assessed mental health problems and services use appear to be very stable among the general population (cf. [33] ). We found no indications that on population level the prevalence nor the the incidence of anxiety and depression symptoms, sleep problems, fatigue, disabilities due to health problems, use of medicines for sleep problems, anxiety and depression, and mental health services use increased in November-December 2020, showing almost identical results. Results did not show differences between mental health problems and mental health services use at T1 and T2 on the one side, and problems and use at T3 on the other side, except among 50-64 years old respondents and among 65+ old respondents.

Results showed a small significant decrease in the prevalence of anxiety and depression symptoms at T3 (13.3%) compared to T1 (14.6%) and T2 (15.1%), and a small significant decrease in the use of mental health services at T3 (2.2%) compare to T1 (3.5%) and T2 (3.1%).

Our results about mental health problems seem to differ from almost all identified COVID-19 studies in the UK and US, but these studies focused on mental health problems until the summer of 2020.

Importantly, in our previous study [20] assessing anxiety and depression symptoms until the summer of 2020 (June), like the study of Breslau et al. [16] and Hyland et al. [34] , no increase in prevalence compared to November-December 2019 was observed. Van Tilburg reported a similar finding et al. [19] among older respondents. As described, in the study of Breslau et al. [16] also no differences between the past-month prevalence of serious psychological distress in May 2020 and past-year prevalence assessed in February 2019 were found. In addition, they found an incidence of 13.7% when distinguishing K6 scores in low-distress versus mild/moderate-serious distress, and an incidence of 4.9% when distinguishing K6 scores in lowmild/moderate distress versus serious distress. The last incidence number, although we used the MHI-5, seem to be close to our incidence number for severe anxiety and depression symptom levels at T2 (3.7%) and T3 (3.3%). The extent to which the incidence of mental health problems after the COVID-19 outbreak in the UK and US differed from the incidence before the outbreak is unknown. Nevertheless, in our previous study [18] we found no indications that the recovery of symptoms after the outbreak differed from the recovery before the outbreak. We are not aware of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ;

COVID-19 studies to compare our findings on sleep problems, fatigue, use of pharmaceuticals, and use of mental health services use with.

How can we, given the outcomes of several studies showing an increase in mental health problems [9] [10] [11] [12] [13] [14] [15] [16] [17] , understand the contradicting results of the present study? In addition, in our previous study [18] we observed a significant increase in emotional loneliness which is considered a risk factor for future mental health problems [33, 34] . Current findings indicate that, despite the observed increase in loneliness until the summer of 2020, the prevalence of anxiety and depression symptoms did not increase among the general population nor in different age categories.

Several elements, other than the resilience of people [3] [4] [5] , may play a role and may help explain these differences, but future empirical research is required to examine and test these elements and explanations. First, unemployment might be a cause for increases in mental health problems [35] but unemployment remained relatively stable in the Netherlands during the COVID-19 outbreak whereas they increased strongly in the US in March and April 2020.

However, also in the UK the unemployment figures did not rise as dramatically as in the US in the first two months after the outbreak. From May 2020 on, due to the COVID-19 recovery programs put in place, the unemployment figures declined again strongly in the US whereas they remained stable in the UK and the Netherlands [38] . Hence, the unemployment incidence might explain some of the differences with the US results but they cannot explain the differences with the UK findings, even though it might still be that support in the UK for mental health problems is poorer than in the Netherlands. A recent report by Statistics Netherlands [39] showed that in the period July 2020-September 2020, 83% of the Dutch resident were positive about their general health, compared to 79-80% in the same period in 2017, 2018 and 2019. In addition, the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Furthermore, mental disorders in the US were much more prevalent in the US than in the Netherlands which may increase the risk for higher post-outbreak mental health problems [41] . It might be that the Dutch welfare system provide better support to people with mental health issues during the COVID-19 outbreak or to people who ran into mental health issues after the outbreak than the US or UK welfare system does.

The absence of an increase of mental health problems between T1 and T2 on the one side and T3 on the other side does not indicate that the COVID-19 outbreak has not negatively affected the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.27.21251952 doi: medRxiv preprint mental health of individuals. As shown by the incidence rates, a minority suffer from mental health problems not experienced one year earlier that may be partly related to the disruptive effects of the COVID-19 pandemic. In addition, besides this pandemic, on a yearly basis about 40% of the adults is confronted with potentially traumatic and life-events that increase the risk for mental health problems among those confronted with these events [42, 43] . There are no valid reasons to assume that those events put the mental health less at risk because of this COVID-19

pandemic. The stress sensitization model suggests otherwise [44] . In other words, without ignoring the drastic societal effects of this pandemic we should be aware this pandemic does not occur in a vacuum. The very strong predictive values of assessed previous mental health problems clearly demonstrate, as in the study by Breslau et al. [16] , this aspect. Perhaps this pandemic partly reveals mental health problems and mental health problems patterns that were already present before the pandemic but, because of the large (media and scientific) attention towards the mental health effects [7, 45] , become more visible because of the pandemic. For example, the number of studies indexed in Pubmed that can be retrieved with the keyword depression is 28,762 with publication date 2018, 30,232 with publication date 2019, and 35,571 with publication date. In 2020, 2,073 were corona or COVID-19 related. An increased visibility of mental health problems should not be confused with an (strong) increased prevalence of mental health problems. In either way, this underscores the relevance of non-retrospective pre-COVID mental health assessment among post-COVID-19 population-based probability samples.

Although our results showed very clear patterns, some limitations need to be discussed when interpreting and using the outcomes of this study. We did not conduct clinical interviews that . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.27.21251952 doi: medRxiv preprint would certainly have enriched our study. Although our results do not point in the direction of a strong post-COVID-19 outbreak increase of mental disorders, future studies using clinical interviews will provide further insight in this topic. We extended previous COVID-19 studies by assessing sleep problems, fatigue, use of medicines for sleep problems, anxiety and depression, disabilities due to health problems, and mental health services utilization. However, future studies focusing on other mental health problems such as eating problems, panic attacks, phobias, alcohol and drug misuse, and low self-esteem are warranted. The three surveys had a one-year time interval. Although we examined anxiety and depression symptoms in March 2019, March 2020 and June 2020 in previous studies, we cannot rule out the possibility that significant increases and decreases can be observed using shorter time intervals. The last survey in the present study was conducted in November-December 2020. How this pandemic will develop in the next year is uncertain. Monitoring of mental health of the general population is therefore needed, also because the duration of this pandemic on the longer term may undermine the capacities of individuals to cope with the consequences. It is unclear to what extent the results can be generalized to other developed countries who were hit harder by the COVID-19 pandemic.

Finally, this study focused on adults and did not include children and adolescents who might be affected differently. At T3, the youngest respondent was 20 years old. Nevertheless, the prospective study design, the use of a large population-based probability sample, the high response rates, a non-response nor being related to our dependent variables, and the weighting of data using 16 demographic profiles of the Dutch population are major strengths of the present study.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.27.21251952 doi: medRxiv preprint

COVID-19) Weekly Epidemiological Update and Weekly Operational Update

WHO. Coronavirus disease (COVID-19): Vaccines

Conservation of resources. A new attempt at conceptualizing stress

Social and psychological resources and adaptation

Psychological adjustment during the global outbreak of COVID-19: A resilience perspective

Don't panic! Short and long term psychological reactions to the new terrorism: the role of information and the authorities

The psychological impact of COVID-19 pandemic lockdowns: a review and meta-analysis of longitudinal studies and natural experiments

Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population

COVID-19 and mental health deterioration by ethnicity and gender in the UK

Mental health and health behaviours before and during the initial phase of the COVID-19 lockdown: longitudinal analyses of the UK Household Longitudinal Study

Longitudinal changes in mental health and the COVID-19 pandemic: evidence from the UK Household Longitudinal Study

Census Bureau-assessed prevalence of anxiety and depressive symptoms in 2019 and during the 2020 COVID-19 pandemic

Psychological distress and loneliness reported by US adults

Depression reported by US

A longitudinal study of psychological distress in the United States before and during the COVID-19 pandemic

Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic

Anxiety and depression symptoms, and lack of emotional support among the general population before and during the COVID-19 pandemic. A prospective national study on prevalence and risk factors

Loneliness and mental health during the COVID-19 pandemic: A study among Dutch older adults

The mental health benefits of employment: Results of a systematic meta-review

Multimorbidity and depression: A systematic review and meta-analysis

Factors associated with health service utilisation for common mental disorders: a systematic review

The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013

Almost 169 thousand people died in 2020, 10 percent more than expected

An efficient method of identifying major depression and panic disorder in primary care

Een beschrijving van de MHI-5 in de gezondheidsmodule van het Permanent Onderzoek Leefsituatie [A Description of the MHI-5 in the Health Module of Permanent Research of Living Conditions

Statistics Netherlands

Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care

PDF/26c7ea80-01d8-420ebdc6-e9d5f6578e7c

Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2

Anxiety and depression in the Republic of Ireland during the COVID-19 pandemic

An overview of systematic reviews on the public health consequences of social isolation and loneliness

Psychological and physical well-being during unemployment: a meta-analytic study

Unemployment rate (indicator)

Health in Corona times

Chatterji S; WHO World Mental Health Survey Consortium. Prevalence, severity, and Mental Health Surveys

The influence of major life events and personality traits on the stability of affective well-being

Which groups affected by Potentially Traumatic Events (PTEs) are most at risk for a lack of social support? A prospective population-based study on the 12-month prevalence of PTEs and risk factors for a lack of post-event social support

Stress sensitivity and stress sensitization in psychopathology: an introduction to the special section

Early impacts of the COVID-19 pandemic on mental health care and on people with mental health conditions: framework synthesis of international experiences and responses

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity